Drug intelligence / Profile preview

ART FILLER

Development stage
Unknown
Lead developer
FILLMED
Modality
Small Molecules
Administration
Intradermal, Submucosal
01

Overview

ART FILLER is a collection of injectable dermal fillers composed of non-animal origin cross-linked hyaluronic acid and 0.3% lidocaine hydrochloride for local anesthesia. Developed with TRI-HYAL technology by Laboratoires Fillmed (formerly Filorga), these fillers combine three types of hyaluronic acid chains—free HA, long chains, and very long chains—to optimize cohesiveness, elasticity, and integration into the skin[1][3][6]. The product line includes formulations tailored for different aesthetic indications: - Fine Lines: For superficial wrinkles such as crow’s feet and perioral lines. - Universal: For medium to deep wrinkles (e.g., nasolabial folds) and moderate volume restoration. - Volume: For restoring or creating facial volume in areas like temples, cheeks, chin, and jawline. - Lips Soft: For soft lip augmentation and perioral wrinkle correction. Upon injection into the appropriate dermal layer or submucosa (for lips), the gel provides immediate volumization by physically filling depressions. Hyaluronic acid also attracts water molecules to enhance hydration and skin suppleness[6][8]. Results are typically visible immediately after treatment with effects lasting up to 12–18 months depending on formulation and patient factors[1][9].

Brand names
ART FILLERART FILLER UNIVERSALART FILLER VOLUMEART FILLER LIPS SOFTART FILLER FINE LINES
Other names
Fillmed Art FillerFilorga Art Filler
02

Targets

CD44 (CD44 antigen)

Beyond the preview

Go deeper on ART FILLER.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ART FILLER.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call